Memo to NCSD Members: Fiscal Year 2023 Appropriations
February 9, 2023
Early this morning, Congress announced the final appropriations package for fiscal year 2023 (FY’23), which we expect to be passed by the end of the week and subsequently signed by the president. NCSD is thrilled to share that for FY’23, there will be a historic $10 million increase in federal funding for STD prevention.
Our press release applauding the funding package can be found here.
The final bill also directs the CDC to move the grant year by at least one month – getting us one step closer to reducing some of the administrative burdens our members unfortunately have become accustomed to.
For those who followed the process closely, as we expected, compromises had to be made in order to get the bill done before the end of the year. The final funding levels across the board—and specifically for DSTDP—are slightly less than the funding levels proposed by Senate democrats and the House earlier this year. However, we are incredibly pleased overall with the increases in funding from FY’22, which represents a significant down payment in our shared work.
The bill does include some disappointments. The CDC’s Division of Adolescent and School Health only received a $2 million increase, much less than was proposed by both chambers earlier this year. Additionally, Title X Family Planning and the Teen Pregnancy Prevention Program will see no funding increases this year, despite the strain being felt across the country by the Dobbs decision. And the package includes no funding for the mpox response.
Along with the funding amounts outlined in the chart below, the final funding package provides additional direction to the administration that will support our field, including:
Encouraging the CDC to hold harmless PCHD funding so that no grantee receives less than the amount received in FY’22;
Encouraging CDC to work with other agencies to address the high rates of STIs;
Instructing the CDC to expand DASH’s school health activities;
Urging HRSA to expand efforts to increase multiple prenatal screening and testing for congenital syphilis (CS) throughout pregnancies to detect and treat CS;
Urging CMS to collaborate with DSTDP to develop a screening, treatment, and education initiative under Medicaid; and
Directing the CDC, through the Ending the HIV Epidemic Initiative, to increase equitable access to PrEP.
Next year, NCSD will work to build on these successes with our existing supporters and developing champions with the newly elected members of Congress.
The chart below includes enacted funding from FY20-FY’23. A more detailed chart, including the president’s budget proposal for FY’23 and funding levels going back to FY’19 can be found here.
Final FY20 Funding
Final FY21 Funding
Final FY’22 Funding
Final FY’23 Funding
CDC – National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Infections (STIs), and Tuberculosis Prevention
CDC – Division of STD Prevention (DSTDP)
CDC – Domestic HIV Prevention (DHP)
CDC – Division of Adolescent and School Health (DASH)
CDC – Division of Viral Hepatitis
CDC – Division of Tuberculosis Elimination
CDC – Infectious Diseases and Opioid Epidemic
CDC – Ending the HIV Epidemic
HRSA – Ryan White – Total
HRSA – Ryan White – Ending the HIV Epidemic
HRSA – Community Health Centers
HRSA – Community Health Centers – Ending the HIV Epidemic
HRSA – Title X Family Planning Program
Teen Pregnancy Prevention Program (TPP)
ACF – “Sexual Risk Avoidance” – Abstinence-Only Program
Secretary’s Minority AIDS Initiative (MIA)
Housing for People Living with AIDS (HOPWA)
NIH – Office of AIDS Research
Final Funding Levels
If you are interested in reading the final joint explanatory statement of the managers, which provides the funding details for these programs, it’s accessible here. And the House report released earlier this year—which carries the same weight as language included in the joint explanatory statement of the managers—is accessible here.
Congratulations to all who made this win possible—onward!